Tobrex · DIN 00614254 · 0.3% · Oph Oint
General benefitMarketed · checked November 18, 2026
StatusGeneral benefit
Write on scriptno code needed
Patient paysODB senior: $100/program-year deductible
• Then up to $6.11 per prescription
Or, if enrolled in the Seniors Co-Payment Program (income-tested; individual net income below $25,480 for Aug 2026–Jul 2027): no deductible, up to $2 per prescription
Private plan not entered. Private-plan coverage, and how it coordinates with public programs, is not determined here; the Ontario public-program lines on this page remain conditional on the entered details and the program rules.
No interchangeable product listed in the Ontario extract
Tobrex · DIN 00614254
Manufacturer: Novartis Pharma Canada Inc.; listing date 1996-10-01
Health Canada: Marketed since 2018-08-02 · brand TOBREX · ATC S01AA12 TOBRAMYCIN · form Ointment · route Ophthalmic · ingredients TOBRAMYCIN 0.3 %/W/W · company Novartis pharmaceuticals canada inc · schedule Prescription
Tobrex: Formulary list price $2.75 per unit (the source does not state the unit; exact figure $2.7514). What the ministry pays, not the patient.
Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 00614254)
Source record
DIN 00614254: Tobrex
Raw flags: sec3=Y
Item: 520404024; group id 584; item number 1539; lccId None; manufacturer id NOV
Source form: Oph Oint; strength: 0.3%
Recorded listing: General benefit
Source prices (unrounded): $2.7514; ministry $2.7514
Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=00614254
Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=5707
Shortage status: not checked (no credentials)